Carregant...
New treatment options for inflammatory bowel diseases
The advent of anti-TNF agents has dramatically changed the treatment algorithms for IBD in the last 15 years, but primarily and more importantly secondary loss of response is often observed. Fortunately , new treatment options have been actively explored and some have already entered our clinical pr...
Guardat en:
| Publicat a: | J Gastroenterol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Japan
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5910475/ https://ncbi.nlm.nih.gov/pubmed/29556726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-018-1449-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|